Localized Leiomyosarcoma Biomarker Protocol — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Localized Leiomyosarcoma Biomarker Protocol — Stella

Home/Leiomyosarcoma/

View on ClinicalTrials.gov

Recruiting

Back to Leiomyosarcoma trials

Trial locations(3 sites)

United States

University of Michigan, Ann Arbor, Michigan

Mayo Clinic, Rochester, Minnesota

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

National Cancer Institute (NCI)

Enrollment target

~40 participants

Started

April 2023

Primary completion

June 2026

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.